{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:19:05Z","timestamp":1787771945754,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mantle cell lymphoma (MCL) constitutes 3%\u201310% of non-Hodgkin lymphoma and is characterized by\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    (11:14)(q13;q32). The common presentation is generalized lymphadenopathy with weight loss, infrequently night sweats, and fever. Among histological subtypes of MCL, the blastoid variant of MCL constitutes 10%\u201315% of all the cases. It is challenging to diagnose the blastoid variant of MCL based on its morphology alone as it mimics large B-cell lymphoma. Hence, the immunophenotyping and molecular studies aid in its correct diagnosis. We report an elderly man diagnosed with blastoid variant MCL. He presented with disseminated soft-tissue and subcutaneous nodules, and showed aberrant CD10 expression. Presentation of the extranodal site and aberrant CD10 expressions carries an overall poor prognosis. CD10-positive MCL can be mistaken for large B-cell lymphoma.\n                  <\/jats:p>","DOI":"10.4103\/ijabmr.ijabmr_406_23","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T09:00:29Z","timestamp":1708419629000},"page":"63-66","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Blastoid Variant of Mantle Cell Lymphoma with Extranodal Presentation and Aberrant CD10 Expression"],"prefix":"10.4103","volume":"14","author":[{"given":"Arthy","family":"Raman","sequence":"first","affiliation":[{"name":"Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree Rekha","family":"Jinkala","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roobashri","family":"Murugan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhu","family":"Manivannan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"R1-20240902","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.18632\/oncotarget.23571","article-title":"CD10-positive mantle cell lymphoma:Clinicopathologic and prognostic study of 30 cases","volume":"9","author":"Xu","year":"2018","journal-title":"Oncotarget"},{"key":"R2-20240902","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0733-8635(18)30189-X","article-title":"Mantle-cell lymphomas of the skin","volume":"12","author":"Geerts","year":"1994","journal-title":"Dermatol Clin"},{"key":"R4-20240902","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tripleo.2009.08.010","article-title":"Mantle cell lymphoma of the oral cavity:Case series and comprehensive review of the literature","volume":"109","author":"Guggisberg","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R5-20240902","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1159\/000507921","article-title":"Mantle cell lymphoma presenting as a subcutaneous mass of the right leg","volume":"13","author":"Fajardo","year":"2020","journal-title":"Case Rep Oncol"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/PAS.0000000000000445","article-title":"Skin involvement of mantle cell lymphoma may mimic primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"39","author":"Wehkamp","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR","volume":"94","author":"Quintanilla-Martinez","year":"2009","journal-title":"Haematologica"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"key":"R10-20240902","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1309\/U98ADVKUC26R2RJA","article-title":"B-cell lymphomas with coexpression of CD5 and CD10","volume":"119","author":"Dong","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1309\/T88X-71U4-WC0R-2531","article-title":"Assessment of CD10 in the diagnosis of small B-cell lymphomas:A multiparameter flow cytometric study","volume":"117","author":"Xu","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R12-20240902","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/ajcp\/aqy097.265","article-title":"Potential prognostic significance of aberrant CD10 positivity in mantle cell lymphoma","volume":"150","author":"Ziemba","year":"2018","journal-title":"Am J Clin Pathol"}],"container-title":["International Journal of Applied &amp; Basic Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijabmr.ijabmr_406_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:21:52Z","timestamp":1787768512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijabmr.ijabmr_406_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijabmr.ijabmr_406_23","relation":{},"ISSN":["2229-516X","2248-9606"],"issn-type":[{"value":"2229-516X","type":"print"},{"value":"2248-9606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-09-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}